Skip to main content
SpringerLink
Log in

Optimisation of Medical Management of Chronic Rhinosinusitis

  • RHINOLOGY: Chronic Rhinosinusitis (C Philpott, Section Editor)
  • Published:
Current Otorhinolaryngology Reports Aims and scope Submit manuscript

Abstract

Purpose of Review

Chronic rhinosinusitis (CRS) is a common condition and can have a significant impact on quality of life for affected patients. The aetiology is poorly understood leading to the use of a variety of medical treatments to manage the condition, some with little evidence to suggest any benefit.

Recent Findings

Over the last 3 years, research has been carried out investigating alternatives and alterations to many of the current treatment options for CRS. Of these, alternative delivery methods for intranasal corticosteroids and immunomodulation with monoclonal antibodies show the most promise to improve medical treatment of CRS.

Summary

CRS can be a difficult to manage condition with multiple treatment options available; however, many of these have a poor evidence base to support their use. When medical management fails, patients can be subjected to debilitating symptoms and repeated endoscopic sinus operations. New treatments which prevent this cycle could revolutionise current management.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. Hastan D, Fokkens WJ, Bachert C, Newson RB, Bislimovska J, Bockelbrink A, et al. Chronic rhinosinusitis in Europe—an underestimated disease. A GA2LEN study. European Journal of Allergy Clin Immunol. 2011;66(9):1216–23.

    Article  CAS  Google Scholar 

  2. Gliklich RE, Metson R. The health impact of chronic sinusitis in patients seeking otolaryngologic care. (0194–5998 (Print)).

  3. Soler ZM, Eckert MA, Storck K, Schlosser RJ. Cognitive function in chronic rhinosinusitis: a controlled clinical study. Int Forum Allergy Rhinol. 2015;5(11):1010–7.

  4. Fokkens WJ, Lund VJ, Mullol J, Bachert C, Alobid I, Baroody F, Cohen N, et al. EPOS 2012: European position paper on rhinosinusitis and nasal polyps 2012. A summary for otorhinolaryngologists. Rhinology. 2012;50(23):1–298.

  5. Aurora R, Chatterjee D, Hentzleman J, Prasad G, Sindwani R, Sanford T. Contrasting the microbiomes from healthy volunteers and patients with chronic rhinosinusitis. JAMA Otolaryngol Head Neck Surg. 2013;139(12):1328–38.

    Article  PubMed  Google Scholar 

  6. Okano M, Fujiwara T, Makihara S, Fujiwara R, Higaki T, Kariya S, et al. Characterization of IL-18 expression and release in the pathogenesis of chronic rhinosinusitis. Int Arch Allergy Immunol. 2013;160(3):275–86.

    Article  PubMed  CAS  Google Scholar 

  7. Georgitis JW. Nasal hyperthermia and simple irrigation for perennial rhinitis. Changes in inflammatory mediators. Chest. 1994;106(5):1487–92.

  8. Ural A, Oktemer TK, Kizil Y, Ileri F, Uslu S. Impact of isotonic and hypertonic saline solutions on mucociliary activity in various nasal pathologies: clinical study. J Laryngol Otol. 2009;123(5):517–21.

  9. Chong LY, Head K, Hopkins C, Philpott C, Glew S, Scadding G, Burton MJ, Schilder AGM, Cochrane ENT Group Saline irrigation for chronic rhinosinusitis. Cochrane Database Syst Rev 2016(4).

  10. Little P, Stuart B, Mullee M, Thomas T, Johnson S, Leydon G, et al. Effectiveness of steam inhalation and nasal irrigation for chronic or recurrent sinus symptoms in primary care: a pragmatic randomized controlled trial. CMAJ : Can Med Assoc J. 2016;188(13):940–9.

  11. Yu MS, Kim B-H, Kang S-H, Lim DJ. Low-concentration hypochlorous acid nasal irrigation for chronic sinonasal symptoms: a prospective randomized placebo-controlled study. Eur Arch Otorhinolaryngol. 2017;274(3):1527–33.

  12. Cho H-J, Min HJ, Chung HJ, Park D-Y, Seong SY, Yoon J-H, et al. Improved outcomes after low-concentration hypochlorous acid nasal irrigation in pediatric chronic sinusitis. Laryngoscope. 2016;126(4):791–5.

    Article  PubMed  Google Scholar 

  13. Lee VS, Humphreys IM, Purcell PL, Davis GE. Manuka honey sinus irrigation for the treatment of chronic rhinosinusitis: a randomized controlled trial. Int Forum Allergy Rhinol. 2017;7(4):365–72.

  14. Low T-HH, Woods CM, Ullah S, Carney AS. A double-blind randomized controlled trial of normal saline, lactated Ringer’s, and hypertonic saline nasal irrigation solution after endoscopic sinus surgery. Am J Rhinol Allergy. 2014;28(3):225–31.

    Article  PubMed  Google Scholar 

  15. Hashemian F, Baghbanian N, Majd Z, Rouini M-R, Jahanshahi J, Hashemian F. The effect of thyme honey nasal spray on chronic rhinosinusitis: a double-blind randomized controlled clinical trial. Eur Arch Otorhinolaryngol. 2015;272(6):1429–35.

  16. Suh JD, Kennedy DW. Treatment options for chronic rhinosinusitis. Proc Am Thorac Soc. 2011;8(1):132–40.

    Article  PubMed  CAS  Google Scholar 

  17. Derendorf H, Meltzer EO. Molecular and clinical pharmacology of intranasal corticosteroids: clinical and therapeutic implications. Allergy. 2008;63(10):1292–300.

  18. Chong Lee Y, Head K, Hopkins C, Philpott C, Schilder AG, Burton MJ. Intranasal steroids versus placebo or no intervention for chronic rhinosinusitis. Cochrane Database of Syst Rev 2016(4).

  19. Chong LY, Head K, Hopkins C, Philpott C, Burton MJ, Schilder AGM. Different types of intranasal steroids for chronic rhinosinusitis. Cochrane Database Syst Rev 2016(4).

  20. Poletti SC, Batashev I, Reden J, Hummel T. Olfaction in chronic rhinosinusitis: comparing two different endonasal steroid application methods. Eur Arch Otorhinolaryngol. 2017;274(3):1431–5.

  21. Wang C, Lou H, Wang X, Wang Y, Fan E, Li Y, et al. Effect of budesonide transnasal nebulization in patients with eosinophilic chronic rhinosinusitis with nasal polyps. J Allergy Clin Immunol. 2015;135(4):922–929.e6.

    Article  PubMed  CAS  Google Scholar 

  22. Reychler G, Colbrant C, Huart C, Le Guellec S, Vecellio L, Liistro G, et al. Effect of three-drug delivery modalities on olfactory function in chronic sinusitis. Laryngoscope. 2015;125(3):549–55.

    Article  PubMed  CAS  Google Scholar 

  23. Thamboo A, Manji J, Szeitz A, Santos RD, Hathorn I, Gan EC, et al. The safety and efficacy of short-term budesonide delivered via mucosal atomization device for chronic rhinosinusitis without nasal polyposis. Int Forum Allergy Rhinol. 2014;4(5):397–402.

  24. Venkatesan N, Lavigne P, Lavigne F, Hamid Q. Effects of fluticasone furoate on clinical and immunological outcomes (IL-17) for patients with nasal polyposis naive to steroid treatment. Ann Otol Rhinol Laryngol. 2016;125(3):213–8.

    Article  PubMed  Google Scholar 

  25. Head K, Chong LY, Hopkins C, Philpott C, Burton MJ, Schilder AGM. Short-course oral steroids alone for chronic rhinosinusitis. Cochrane Database Syst Rev 2016(4).

  26. Head K, Chong LY, Hopkins C, Philpott C, Schilder AGM, Burton MJ. Short-course oral steroids as an adjunct therapy for chronic rhinosinusitis. Cochrane Database Syst Rev 2016(4).

  27. Wozniak DJ, Keyser R. Effects of subinhibitory concentrations of macrolide antibiotics on Pseudomonas aeruginosa. Chest. 2004;125(2):62–9.

  28. Glowacki R, Tomaszewski KA, Strek P, Tomaszewska IM, Zgorska-Swierzy K, Markiewicz B, et al. The influence of bacterial biofilm on the clinical outcome of chronic rhinosinusitis: a prospective, double-blind, scanning electron microscopy study. Eur Arch Otorhinolaryngol. 2014;271(5):1015–21.

  29. Singh P, Mehta R, Agarwal S, Mishra P. Bacterial biofilm on the sinus mucosa of healthy subjects and patients with chronic rhinosinusitis (with or without nasal polyposis). J Laryngol Otol. 2015;129(1):46–9.

    Article  PubMed  CAS  Google Scholar 

  30. Korkmaz H, Ocal B, Tatar EC, Tatar I, Ozdek A, Saylam G, et al. Biofilms in chronic rhinosinusitis with polyps: is eradication possible? Eur Arch Otorhinolaryngol. 2014;271(10):2695–702.

  31. Merkley MA, Bice TC, Grier A, Strohl AM, Man LX, Gill SR. The effect of antibiotics on the microbiome in acute exacerbations of chronic rhinosinusitis. Int Forum Allergy Rhinol. 2015;5(10):884–93.

  32. Tamaoki J, Kadota J, Takizawa H. Clinical implications of the immunomodulatory effects of macrolides. Am J Med. 2004;8:117

  33. Head K, Chong LY, Piromchai P, Hopkins C, Philpott C, Schilder AGM, et al. Systemic and topical antibiotics for chronic rhinosinusitis. Cochrane Database Syst Rev 2016(4).

  34. Fan Y, Xu R, Hong H, Luo Q, Xia W, Ding M, et al. High and low doses of clarithromycin treatment are associated with different clinical efficacies and immunomodulatory properties in chronic rhinosinusitis. J Laryngol Otol. 2014;128(3):236–41.

    Article  PubMed  CAS  Google Scholar 

  35. B J, A S, C S, H C, S A, S V, et al. The value of a feasibility study into long-term macrolide therapy in chronic rhinosinusitis. Clin Otolaryngol. 2017;42(1):131–8.

    Article  Google Scholar 

  36. Sabino HAC, Valera FCP, Aragon DC, Fantucci MZ, Titoneli CC, Martinez R, et al. Amoxicillin-clavulanate for patients with acute exacerbation of chronic rhinosinusitis: a prospective, double-blinded, placebo-controlled trial. Int Forum Allergy Rhinol. 2017;7(2):135–42.

  37. Sreenath SB, Taylor RJ, Miller JD, Ambrose EC, Rawal RB, Ebert CS Jr, et al. A prospective randomized cohort study evaluating 3 weeks vs 6 weeks of oral antibiotic treatment in the setting of “maximal medical therapy” for chronic rhinosinusitis. Int Forum Allergy Rhinol. 2015;5(9):820–8.

  38. Van Zele T, Gevaert P, Holtappels G, Beule A, Wormald PJ, Mayr S, Hens G, Hellings P, Ebbens FA, Fokkens W, Van Cauwenberge P, Bachert C, et al. Oral steroids and doxycycline: two different approaches to treat nasal polyps. J Allergy Clin Immunol. 2010;125(5):1069–76.

  39. Videler WJ, Badia L, Harvey RJ, Gane S, Georgalas C, van der Meulen FW, et al. Lack of efficacy of long-term, low-dose azithromycin in chronic rhinosinusitis: a randomized controlled trial. Allergy. 2011;66(11):1457–68.

  40. Braun H, Buzina W, Freudenschuss K, Beham A, H S. Eosinophilic fungal rhinosinusitis’: a common disorder in Europe, Laryngoscope. 2003;113(2):264–9.

    Article  PubMed  Google Scholar 

  41. Lackner A, Stammberger H, Buzina W, Freudenschuss K, Panzitt T, Schosteritsch S, et al. Fungi: a normal content of human nasal mucus. Am J Rhinol. 2005;19(2):125–9.

    Article  PubMed  Google Scholar 

  42. Chakrabarti A, Rudramurthy SM, Panda N, Das A, Singh A. Epidemiology of chronic fungal rhinosinusitis in rural India. Mycoses. 2015;58(5):294–302.

    Article  PubMed  Google Scholar 

  43. Philpott CM, Javer AR, Clark A. Allergic fungal rhinosinusitis—a new staging system. D - 0347242. (- 0300-0729 (Print)):- 318–23.

  44. Sacks P-L, Harvey RJ, Rimmer J, Gallagher RM, Sacks R. Topical and systemic antifungal therapy for the symptomatic treatment of chronic rhinosinusitis. Cochrane Database Syst Rev 2011(8).

  45. Cingi C, Muluk NB, Ipci K, Sahin E. Antileukotrienes in upper airway inflammatory diseases. Curr Allergy Asthma Rep. 2015;15(11):64.

    Article  PubMed  CAS  Google Scholar 

  46. Wu X, Hong H, Zuo K, Han M, Li J, Wen W, et al. Expression of leukotriene and its receptors in eosinophilic chronic rhinosinusitis with nasal polyps. Int Forum Allergy Rhinol. 2016;6(1):75–81.

  47. Wilson AM, White PS, Gardiner Q, Nassif R, Lipworth BJ. Effects of leukotriene receptor antagonist therapy in patients with chronic rhinosinusitis in a real life rhinology clinic setting. Rhinology. 2001;39(3):142–6.

    PubMed  CAS  Google Scholar 

  48. Elwany S, Hisham M, Gamaee R The effect of endoscopic sinus surgery on mucociliary clearance in patients with chronic sinusitis. 1998; 255(10):-514.

  49. Han D, Wang N, Zhang L. The effect of myrtol standardized on human nasal ciliary beat frequency and mucociliary transport time. Am J Rhinol Allergy. 2009;23(6):610–4.

    Article  PubMed  Google Scholar 

  50. Braverman I, Wright ED, Wang CG, Eidelman D, Frenkiel S. Human nasal ciliary-beat frequency in normal and chronic sinusitis subjects. J Otolaryngol. 1998;27(3):145–52.

    PubMed  CAS  Google Scholar 

  51. Majima Y, Sakakura Y, Matsubara T, Miyoshi Y. Possible mechanisms of reduction of nasal mucociliary clearance in chronic sinusitis. Clin Otolaryngol Allied Sci. 1986;11(2):55–60.

  52. Chen B, Shaari J, Claire SE, Palmer JN, Chiu AG, Kennedy DW, et al. Altered sinonasal ciliary dynamics in chronic rhinosinusitis. Am J Rhinol. 2006;20(3):325–9.

    Article  PubMed  Google Scholar 

  53. Chiu AG, Palmer JN, Woodworth BA, Doghramji L, Cohen MB, Prince A, Cohen NA, et al. Baby shampoo nasal irrigations for the symptomatic post-functional endoscopic sinus surgery patient. Am J Rhinol. 2008;22(1):34–7.

  54. Raynor EM, Butler A, Guill M, Bent JP 3rd. Nasally inhaled dornase alfa in the postoperative management of chronic sinusitis due to cystic fibrosis. Arch Otolaryngol Head Neck Surg. 2000;126(5):581–3.

    Article  PubMed  CAS  Google Scholar 

  55. Tsetsos N, Goudakos JK, Daskalakis D, Konstantinidis I, Markou K. Monoclonal antibodies for the treatment of chronic rhinosinusitis with nasal polyposis: a systematic review. Rhinology. 2018;56(1):11–21.

    Article  PubMed  CAS  Google Scholar 

  56. De Schryver E, Derycke L, Calus L, Holtappels G, Hellings PW, Van Zele T, et al. The effect of systemic treatments on periostin expression reflects their interference with the eosinophilic inflammation in chronic rhinosinusitis with nasal polyps. Rhinology. 2017;55(2):152–60.

    Article  PubMed  Google Scholar 

  57. Pinto JM, Mehta N, DiTineo M, Wang J, Baroody FM, Naclerio RM. A randomized, double-blind, placebo-controlled trial of anti-IgE for chronic rhinosinusitis. Rhinology. 2010;48(3):318–24.

    PubMed  CAS  Google Scholar 

  58. Gevaert P, Calus L, Van Zele T, Blomme K, De Ruyck N, Bauters W, et al. Omalizumab is effective in allergic and nonallergic patients with nasal polyps and asthma. J Allergy Clin Immunol. 2013;131(1):110–116.e1.

    Article  PubMed  CAS  Google Scholar 

  59. Gevaert P, Van Bruaene N, Cattaert T, Van Steen K, Van Zele T, Acke F, et al. Mepolizumab, a humanized anti-IL-5 mAb, as a treatment option for severe nasal polyposis. J Allergy Clin Immunol. 2011;128(5):989–995.e8.

    Article  PubMed  CAS  Google Scholar 

  60. Bachert C, Mannent L, Naclerio RM, Mullol J, Ferguson BJ, Gevaert P, et al. Effect of subcutaneous dupilumab on nasal polyp burden in patients with chronic sinusitis and nasal polyposis: a randomized clinical trial. JAMA. 2016;315(5):469–79.

    Article  PubMed  CAS  Google Scholar 

  61. Chen J, Zhou Y, Nie J, Wang Y, Zhang L, Shi Q, et al. Bacterial lysate for the prevention of chronic rhinosinusitis recurrence in children. J Laryngol Otol. 2017;131(6):523–8.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Freeman Hospital, Freeman Rd, High Heaton, Newcastle upon Tyne, NE7 7DN, UK

    Joanna Buckley & Sean Carrie

Authors
  1. Joanna Buckley
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Sean Carrie
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Joanna Buckley.

Additional information

This article is part of the Topical Collection on SPECIAL TOPICS: Value Based Care in Otolaryngology

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Buckley, J., Carrie, S. Optimisation of Medical Management of Chronic Rhinosinusitis. Curr Otorhinolaryngol Rep 6, 245–252 (2018). https://doi.org/10.1007/s40136-018-0211-7

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40136-018-0211-7

Keywords

Search

Navigation